TG Therapeutics Inc. (NASDAQ:TGTX) stock is trading lower on Monday after the company reported worse-than-expected second-quarter 2025 earnings. TG Therapeutics reported second-quarter earnings per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback